WRAP Peptides for siRNA Delivery via Amphipathic Self-Assembly
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cell-penetrating peptides (CPPs) face limitations such as low stability, limited membrane permeability, inefficient gene silencing, and cytotoxicity when delivering siRNA into cells, necessitating the development of more effective and less toxic CPPs for therapeutic agent delivery.
Innovation Solution
The development of new short amphipathic peptides composed exclusively of leucine (L), arginine (R), and tryptophan (W) residues, known as WRAP peptides, which are designed to enhance solubility, secondary structure, and uptake efficiency while reducing cytotoxicity, forming nanoparticles with siRNA for efficient cellular delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional cell-penetrating peptides are used for siRNA delivery, then cell penetration capability is achieved, but cytotoxicity and low stability occur
Solution Approach 1:
The patent modifies the amino acid composition parameters of CPPs by restricting residues to only L, R, and W, with specific ratios (4 R, 4 L, and 2-4 W residues). This parameter optimization resolves the contradiction by achieving effective cell penetration while reducing cytotoxicity through controlled residue selection and distribution.
Solution Approach 2:
The invention creates composite peptide structures combining specific amino acid residues (L, R, W) in defined patterns to form amphipathic peptides with optimized properties. This composite approach enables simultaneous achievement of membrane permeability and reduced cytotoxicity through synergistic residue interactions.
2Productivity
If conventional CPPs are used for siRNA delivery, then cellular internalization is achieved, but transfection efficiency is insufficient
Solution Approach 1:
The patent optimizes transfection efficiency by adjusting critical parameters including peptide length (14-16 residues), residue composition ratios, and hydrophobicity balance. These parameter changes enable efficient cellular internalization while ensuring reliable transfection through enhanced peptide-cargo complex formation and endosomal escape.
3Strength
If existing CPP sequences are used, then membrane permeability is achieved, but stability is low
Solution Approach 1:
The invention enhances peptide stability by optimizing structural parameters including the introduction of tryptophan residues that stabilize secondary structure, controlling peptide length within 14-16 residues, and establishing specific L-R-W residue patterns that resist proteolytic degradation while maintaining membrane permeability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The WRAP peptides demonstrate higher transfection efficacy and lower cytotoxicity, enabling effective delivery of cargo molecules into cells with improved stability and specificity, outperforming existing CPPs in terms of knock-down efficiency and safety.
Implementation Method 1
The formation of non-covalent nanoparticles (NPs) has been particularly efficient in the CPP-mediated delivery of oligonucleotides carrying multiple negative charges and therefore able to form electrostatic complexes with cationic peptides.
Implementation Method 2
Amphipathic CPPs contain both hydrophilic and hydrophobic domains necessary for cellular internalization and interaction with the cargo.
Data Source
AI summary
The present invention relates to new peptides comprising an amino acid sequence LL-[X]n-LL, wherein X is selected from R, L and W, and n=10 to 12, and wherein [X]n comprises 4 R, 4 L and between 2 and 4 W, that may be used as cell-penetrating peptides. The present invention also relates to nanoparticles comprising a peptide of the invention and a cargo molecule and uses thereof.